Comparison of Single Incision Scrotal vs Standard Two Incision Inguinal Orchidopexy in Children Under 10 Years.

November 19, 2025 updated by: Ijaz Ul Haq, Children Hospital Faisalabad

Comparison of Single Incision Scrotal Orchidopexy Versus Standard Two Incision Inguinal Orchidopexy in Children With Palpable Undesended Testis in Children Hospital Faisalabad.

This study compares the outcome of single incision scrotal orchidopexy with standard two incision inguinal orchidopexy in children under 10 years of age presented with palpable undesended tesis.The aim is to evaluate operative time,cosmetic outcome and post operative complications.

Study Overview

Detailed Description

All patients fulfilling the inclusion criteria admitted to paediatric surgery will be included by after taking informed consent from parents. Patients will be randomized in to two groups by lottery method.In group A ,orchidopexy is performed through single scrotal incision .In group B, orchidopexy is performed through standard two incision inguinal approach. This study compares the outcome interm of operative time, cosmetic outcome and post operative complications.

Study Type

Interventional

Enrollment (Estimated)

60

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • Punjab Province
      • Faisalābad, Punjab Province, Pakistan
        • Recruiting
        • Children Hospital and Institute of Child Health Faisalabad
        • Contact:
        • Principal Investigator:
          • Haq

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Male children with age 1-10 years. Palpable low -lying undesended tesis.

Exclusion Criteria:

  • Impalpable testis Known bleeding disorder

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Single scrotal incision orchidopexy
Children in this group undergoes single incision scrotal orchidopexy with palpable undesended testis in superficial inguinal canal.
Conventional orchidopexy performed through single scrotal incision
Active Comparator: Standard two incision inguinal orchidopexy
Children in this group undergoes standard two incision inguinal orchidopexy.
Conventional orchidopexy performed through separate inguinal and scrotal incision

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Post operative complications
Time Frame: With in 24 hours -1month after surgery .
Numbers and type of post operative complications (Scrotal hematoma, infection, scrotal edema and testicular atrophy.
With in 24 hours -1month after surgery .

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Cosmetic outcome
Time Frame: 2 weeks after surgery
Cosmetic appearance of surgical scar assessed by standardized scale. Scale score range (1-10) lower score =better cosmetic outcome. Higher core = worse cosmetic outcome
2 weeks after surgery

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

November 1, 2025

Primary Completion (Estimated)

May 1, 2026

Study Completion (Estimated)

July 1, 2026

Study Registration Dates

First Submitted

November 14, 2025

First Submitted That Met QC Criteria

November 14, 2025

First Posted (Estimated)

November 18, 2025

Study Record Updates

Last Update Posted (Actual)

November 24, 2025

Last Update Submitted That Met QC Criteria

November 19, 2025

Last Verified

November 1, 2025

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Undescended Testis

Clinical Trials on Single scrotal incision orchidopexy

Subscribe